Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hoechst launches antidiabetic drug in Germany

Jan. 21, 1997

Human IL-9 reported in patent literature

Jan. 21, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

Troglitazone price-listed in Japan

Jan. 20, 1997

New amylin antagonists from Amylin

Jan. 20, 1997

More antiobesity proteins in the pipeline at Lilly

Jan. 20, 1997

New ACAT inhibitors claimed by DuPont Merck

Jan. 20, 1997

MacroChem to begin clinical trials of SEPA-testosterone

Jan. 17, 1997

AI-401 clinical trial program updated

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...